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Abstract: Single-nucleotide polymorphisms (SNPs) are the simplest and most common type of
DNA variations in the human genome. This class of attractive genetic markers, along with point
mutations, have been associated with the risk of developing a wide range of diseases, including
cancer, cardiovascular diseases, autoimmune diseases, and neurodegenerative diseases. Several
existing methods to detect SNPs and mutations in body fluids have faced limitations. Therefore,
there is a need to focus on developing noninvasive future polymerase chain reaction (PCR)–free tools
to detect low-abundant SNPs in such specimens. The detection of small concentrations of SNPs in
the presence of a large background of wild-type genes is the biggest hurdle. Hence, the screening
and detection of SNPs need efficient and straightforward strategies. Suitable amplification methods
are being explored to avoid high-throughput settings and laborious efforts. Therefore, currently,
DNA sensing methods are being explored for the ultrasensitive detection of SNPs based on the
concept of nanotechnology. Owing to their small size and improved surface area, nanomaterials hold
the extensive capacity to be used as biosensors in the genotyping and highly sensitive recognition
of single-base mismatch in the presence of incomparable wild-type DNA fragments. Different
nanomaterials have been combined with imaging and sensing techniques and amplification methods
to facilitate the less time-consuming and easy detection of SNPs in different diseases. This review
aims to highlight some of the most recent findings on the aspects of nanotechnology-based SNP
sensing methods used for the specific and ultrasensitive detection of low-concentration SNPs and
rare mutations.
Keywords: SNP; nanotechnology; genomic DNA; detection
1. Introduction
Modern diagnostic methods have shown better performance than conventional meth-
ods. Recently, the focus has moved beyond the conventional clinical therapies and gravi-
tated toward individualized therapies, termed “personalized medicine” [1–5]. Personalized
medicine is a wide-ranging and expeditiously advancing field in health care that provides
remarkable access to each patient’s unique genetic, genomic, and clinical characteristics [6].
This new trend in medicine also, called “precision medicine”, addresses distinctive molec-
ular defects present in thousands of genetic abnormalities via the application of various
technologies [7].
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Many efforts have been made in the last 20 years to chart more than 3 million single-
nucleotide polymorphisms (SNPs) in the human genome [8]. These genetic variations
were assumed to be not deleterious to organisms and were primarily studied because
of their clinical significance and application in personalized medicine [9]. In this regard,
broad clinical applications of personalized medicine have been reported for SNPs, such as
risk assessment, screening of different multifactorial diseases, diagnosis, prognosis, and
patient stratification [9,10]. This implies that SNPs could serve as valuable biomarkers for
predicting patient’s response to treatment, adverse effects of drugs, and drug resistance [9].
On the other hand, point mutations are rather subtle changes in DNA; hence, their detection
is challenging [11]. This problem has gained much attention, and due to the importance of
identifying SNPs in humans, multiple genotyping methods have been developed. However,
similar to the SNPs, precise detection of low-abundance somatic point mutations is a critical
step in characterizing disease genomics [12].
Conventional genotyping methods or more advanced array comparative genomic
hybridization methods have proven to be reliable genomic technologies used to evaluate
disease incidence and to reveal the impact of SNPs on disease progression [13,14]. Some
serological tests such as enzyme-linked immunosorbent assay (ELISA), polymerase chain
reaction (PCR), real-time reverse transcription PCR (RT-PCR), luciferase immunoprecipi-
tation system (LIPS), next-generation sequencing (NGS), and loop-mediated isothermal
amplification (LAMP) have already been used for the diagnosis of diseases, identification
of SNPs, and/or rapid detection of pathogens [15–17]. However, they are less sensitive,
time-consuming, and relatively expensive for such purposes [18]. Among these, the tetra
amplification refractory mutation system-PCR (T-ARMS-PCR), PCR-restriction fragment
length polymorphism (PCR-RFLP), RT-PCR high-resolution melt (HRM), and PCR-single-
strand conformation polymorphism (PCR-SSCP) are independent diagnostic methods
widely used in SNP genotyping. However, the efficacy of these techniques is hindered by
many optimizations and lack of experience [19,20].
Next-generation sequencing (NGS) is a parallel sequencing method developed to
extend the resolution and scale of genomic investigations. Despite recent advancements
made using NGS platforms, a major obstacle in the application of this technique for SNP
detection remains in data processing steps [21]. It has been reported that most mainstream
NGS technologies exploit short-read lengths, which limits the detection of structural
variations/mutations and the ability to conduct de novo sequencing [22]. Wang et al.,
showed that NGS has lower sequence coverage and poor SNP-detection capability in the
gene’s regulatory regions [23]. Furthermore, several NGS systems make use of microtiter
plates for sample partitioning. These methods are instrumentally complex and limited in
their partitioning capacity [24]. Hence, the use of nanoscale droplets has been suggested to
yield large-scale partitioning more efficiently and rapidly [25].
As a burgeoning field, nanotechnology uses nanoscale materials for many biomed-
ical applications, including gene therapy drug delivery, tissue engineering, etc. [26–30].
Controlling the size of nanomaterials contributes to the emergence of new microscopic
properties [31–33]. For example, a nanofluid is a fluid containing nanometer-sized particles,
called nanoparticles. These fluids are engineered colloidal suspensions of nanoparticles
in a base fluid. The nanoparticles used in nanofluids are typically made of metals, oxides,
carbides, or carbon nanotubes [34–39]. This is interesting because DNA has physical prop-
erties that can be utilized for the bottom-up construction of nanostructures [40]. The high
flexibility of DNA as a single strand enables this molecule to increase its rigidity by 50 fold
as a double strand, creating the basis for using this genetic material as a nanoscale building
block [40,41].
Lately, nanotechnology has revolutionized our ability to better detect SNP mutations
and understand the genetic basis of numerous complex and common disorders. Thanks
to their easy operation and high specificity, the application of these nanobased devices
has been spotlighted as ideal tools for detecting nucleic acids, SNPs, or point mutations.
In this context, Li and colleagues [42] designed branched DNA structures with colored
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fluorophores, named nanobarcodes, and used them to detect the presence or absence of
pathogenic DNA fragments. Guo et al. [43] developed a label-free colorimetric system to
detect SNPs using novel hemin–graphene hybrid nanosheets with intrinsic peroxidase-like
activity. Goldsworthy and coworkers designed smart nanodevices based on RNA bind-
ing aptamers as a novel system for nucleic acid detection [44]. Xu’s research team [45]
developed shell-engineered nanoparticles (NPs) coated with silver (Ag) and gold (Au)
and observed a significant improvement in the sensitivity of PCR-based DNA detection.
Patolsky et al. [46] incorporated biotin labels into DNA replicas associated with mag-
netic particles as a nanodevice for accurate DNA detection. The combination of NGS
and nanotechnology for detecting SNPs have also gained much attention. In this respect,
Siravegna and colleagues combined BEAMing (nanobeads, emulsion, amplification, and
magnetics), droplet digital PCR, NGS, and bioinformatics analyses to accurately geno-
type genetic variations associated with colorectal cancer during treatment with epithelial
growth factor receptor (EGFR)–specific antibodies [47]. Magnetic nanoparticles (MNPs)
have been shown to increase the throughput for NGS [48]. Baker et al. prepared NGS
libraries for constructing the cystic fibrosis transmembrane conductance regulator (CFTR)
gene variations using Illumina MiSeq NGS system and magnetic beads [49]. Hertz and
coworkers efficiently used MNPs and the Illumina MiSeq NGS technique for genotyping
DNA variations that contributed to the occurrence of sudden infant death syndrome [50].
Such methodologies have also shown promising implications for designing personalized
treatments of diverse diseases.
Furthermore, nanotechnology-enhanced electrochemical sensors have shown great
promise for detecting mismatched base pairs in DNA [51,52]. Compared with previous
works, Hwang et al. [53] showed that using a DNA tweezers probe with high-quality
graphene field-effect transistor enhances the sensitivity of SNP detection by more than
1000 fold. Designing DNA carriers containing only one single base difference can help
to recognize DNA strands. Therefore, it is suggested as an alternative strategy toward
detecting SNPs or mutations at a single-molecule level [54].
Single genetic variations play a crucial role as molecular biomarkers in medical and
diagnostic applications. In the present article, we attempted to provide a comprehensive
review of the role of nanotechnology in detecting SNPs for their application in personal-
ized medicine.
2. What Are SNPs?
Genetic variations in the human genome are considered an emerging resource for
studying complex diseases. As the simplest form of DNA variation among individu-
als, SNPs have gained much attention for better understanding the etiology of complex
diseases [8,55]. SNPs might influence divergent traits, which is commonly the basis of
predicting traits or susceptibility to diseases. They can be transitions or transversions at
the frequency of approximately one in a thousand base pairs (bp) [56]. It has been reported
that almost half of SNPs occur in the noncoding regions of DNA, 25% are synonymous
or silent mutations, and the remaining 25% are missense mutations [57]. It was previ-
ously hypothesized that silent SNPs do not influence gene function and haplotype because
they do not change the encoded amino acids [8], but this hypothesis was later proved
wrong [58]. Nonsynonymous SNPs, however, affect gene expression, stability of messenger
RNA (mRNA), subcellular localization of mRNA/proteins, and the translation process as
well [8,59–61]. By definition, an SNP has a minor allele frequency >1% in a population [62].
In other words, SNPs arise due to the presence of point mutations in populations.
3. Clinical Significance of SNP Mutations
SNPs, in the presence or absence of other risk factors, are responsible for the sus-
ceptibility of individuals to multifactorial diseases and may determine the phenotypic
expression of such diseases [63,64]. This has made predictive SNPs excellent tools for
medical testing and a safer individualized prognostic marker [65]. Nevertheless, genetic
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variations discovered by genome-wide association studies (GWAS) constitute a minor frac-
tion of SNPs of complex traits in humans, and the remaining heritability can be explained
by incomplete linkage disequilibrium between genotyped SNPs and casual variations
having low allele frequencies [66].
Essentially, the presence of a heterozygote allele may not change the risk of developing
a disease, but a homozygote allele of the same SNP significantly affects susceptibility to
a complex polygenic disease [67]. Recently, germline and somatic sequence SNPs in
coding and/or noncoding DNA regions have been largely investigated for their role in
the onset of cancer [68,69], inflammatory diseases [70,71], eye diseases, cardiovascular
diseases [72,73], kidney diseases, endocrine disorders, skin diseases [74,75], psychological
diseases and anxiety disorders, gynecological diseases, etc. Interestingly, a large number of
population-based studies reported an association between the studied variant and disease
risk. Synergistic effects of the risk alleles of some SNPs with environmental factors on the
susceptibility to such diseases were also reported in several studies [76,77]. Point mutations
have been introduced as a source of de novo genetic diseases [78]. Therefore, gaining a
better understanding of the role of genetic variations in the etiology of the conditions above
will expand our horizons for designing such curative strategies.
4. Detection of SNPs
4.1. Current Methods
SNPs are often hard to differentiate from other wild-type DNAs because only one
base pair is changed in the DNA sequence [79]. The detection in such cases needs sub-
stantial amplification by sensitive techniques. However, factors such as the utilization of
DNA polymerases, several primers, time-consuming strict working environment, and the
possibility of contamination make techniques such as PCR a hectic procedure [80].
Unlike traditional DNA restriction fragment length polymorphisms (RFLPs) or poly-
merase chain reaction (PCR)–based markers that depend on unified detection methods,
SNPs can be identified using various methods, with new ones emerging every year. Around
20 different SNP detection approaches have been identified so far, consisting of various com-
binations of different allele-discrimination chemistries and signal detection systems [81].
SNP detection strategies were initially focused on gel electrophoresis, such as cleaved
amplified polymorphic sequence (CAPS) labeling [82], allele-specific PCR (AS-PCR) [83],
PCR-single-strand conformation polymorphism (PCR-SSCP) [84], and denatured gradient
gel electrophoresis (DGGE) [85], among others. These techniques, however, were not
appropriate for large-scale procedures, and only a small percentage of SNPs could be iden-
tified, with low-frequency signals being ignored. SNPs were identified using greater and
automatized methods in addition to gel-electrophoresis-based methods, such as DNA se-
quencing and DNA microarray [86], denaturing high-performance liquid chromatography
(DHPLC) [87], matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) [88],
and high-resolution melting (HRM) [89]. These low-throughput approaches, on the other
hand, have a high instrument and sample preparation demands. Of note, DNA sequencing
and DNA microarray are the most commonly used methods for SNP identification these
days because they are high-throughput and cost-effective approaches. Nevertheless, there
is a need for highly specific detection of SNPs, and nanotechnology-based methods can be
a final solution for this purpose.
4.2. Nanotechnology-Based Methods
Nanotechnology holds promising results in identifying SNPs by various principles,
such as partial aggregation upon recognizing target DNA. Moreover, the signal amplifica-
tion can be solely achieved using optical nanocarriers that may further be improved using
hybrid techniques, such as merging the sensing methods with nanotechnology. Au, silica,
Ag, graphene, and quantum-based nanostructures have been widely studied in diagnostic
applications in the past. Hence, owing to their positive outcomes, they are also being
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explored in recognition of SNPs. A general diagram representing the basic idea of SNP
detection is shown in Figure 1.
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4.2.1. Ultrasensitive Hybrid Nanotechnology
Lately, various SNPs detection procedures have been introduced. Few of these are
surface-enhanced Raman scattering, high-resolution DNA melting, hybridization chain
reactions, and single molecular fluorescence [90–93]. But all the techniques lack precision
and se sitivity to the specific nzyme recognition site. Currently, procedures such as
ligase-b sed approaches are being studi d as they may work with various targets with
significant SNPs detection. Ultrasensitive detection of SNPs makes it possible not only to
diagnose the disease but also to predict the relapse [94]. Ultra-sensitivity can be achieved
by coupling the NPs to the ligand-based procedures. MNPs are popular in this regard
because of their stability and homogenous dispersions. Moreover, they are also capable of
amplification of enzymatic signaling [95].
One such research focused on the MNPs for the detection of SNP. MNP-signal-DNA-
ligation was introduced to impr ve th target DNA to enzyme conversion ability. The MNP
nanobead poly-enz e enabled the signal amplification by producing copies of enzymes
for each captured target DNA. The whole method improved the sensitivity and detection of
cancer genetic mutations such as V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog
(KRAS) gene mutations. These somatic mutations are common in lung and colorectal
cancers and were used as a model DNA target in the study [96]. The method used in the
research utilized the hybrid approach in which MNPs were combined with poly-enzyme
nan bead signal amplification. The nanobead were tagged with copies of horseradish
peroxidase (HRP) to enhance the signal amplification power. The pe fe t- atch target
DNA presented biotinylated signal-DNA on the MNP to allow binding of neutravidin HRP.
This method is an ultrasensitive approach to detect SNPs linked to cancer. Biotinylated
signal-DNA and MNP-linked capture DNA sandwiched the target with high efficiency
and performed ligation to improve the SNP detection. The results demonstrated that the
procedure provided high discrimination between the perfect-match target DNA and its
cancer-linked SNPs. It detected a 1 fM perfect-match target DNA in the presence of 100-fold
single-base-mismatch targets.
Currently, isothermal amplification techniques re being exploited to target amplifica-
tion for SNP recognition. One such technique is loop-mediated isothermal amplification
(LAMP), which is highly specific and efficient in targeting amplification [97]. The method
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is also used in the characterization of a specific SNP by an allele-specific LAMP. This
technique is being studied in drug resistance and the detection of complex disorders.
Nanotechnology is being used to characterize specific DNA sequences with precision.
Allele-specific LAMP amplification was used in a study, and Au nanoprobes were also used
because of their optical properties. Au nanoprobes yield a different color in the absence
and presence of complementary targets. Mismatched DNA aggregates Au nanoprobes
creating blue color, whereas unaltered DNA does not, leading to red color. The research
focused on the screening of the SNP related to lactose intolerance. The turnaround time for
amplification was found to be 3 h in the presence of Au nanoprobes. The Au nanoprobes
significantly interpreted the allele-specific amplified product in less than 15 min. This
novel idea is an excellent approach for diagnosing the most commonly found intolerances
in humans [98].
Similarly, nanotechnology was explored for the diagnosis of cancer. The blood of
cancer patients has elevated levels of circulating DNA, which might be due to high cellular
apoptosis and lysis of cancer cells resulting in a mixture of wild-type DNA along with
mutant DNA [99]. The circulating tumor DNA (ctDNA) is the mutant DNA but can be
present in various types of cancer. The extremely low levels of ctDNA are difficult to
detect with accuracy amid the wild-type DNA concentrations. Hence, AuNPs were used
along with MutS protein and a microcantilever to diagnose ctDNA. This specific enzyme is
present in Escherichia coli and can bind with SNPs through a hydrogen bond by initiating the
mismatch repair system. A simple adsorption procedure, molecular dynamic simulation,
was used to bind the MutS protein to AuNPs. Moreover, a microcantilever resonator was
used to detect the target by identifying the frequency changes and, hence, was employed
as the bio-nanosensor. AuNPs amplified the mutant DNA signal on the microcantilever,
which used thiolated DNAs as probe DNAs. The method efficiently detected the KRAS
mutations from other ctDNAs. This specific oncogene is present in non-small-cell lung
cancer. AuNPs-MutS significantly increased the mass of the cantilever in the presence of
mutant DNA. The use of AuNPs improved the selectivity of the detection by using MutS.
This novel technique accurately diagnosed the disease-related SNPs out of all the other
wild-type DNAs [100].
Lately, an interesting technique called enzymatic biofuel cells (EBFCs) has gained
attention in biosensing applications. EBFCs can generate electrical energy from biofu-
els [101]. EBFCs are easy to develop with simple instrumentation, but there is a limitation
to their use because of low sensitivity toward targets. A recent study investigated the
EBFCs integrated with a DNA amplification strategy [102]. The self-powered ultrasensitive
biosensor for detecting SNPs was fabricated by combining DNA hybridization chain (HCR)
and toehold-mediated strand displacement reaction (SDR). EBFCs were built of a glucose
dehydrogenase bioanode and the capture probe of AuNPs. The use of AuNPs improved the
amplification of the signal and facilitated higher sensitivity. DNA HCR and SDR reacted to
produce a long double-helix chain in the presence of a target sequence. The electrostatic
interaction between the double-helix chain and (Ru(NH3)6)3+ produced voltage in the
circuit, exhibiting the detection of SNPs. The strategy efficiently identified the p53 gene
fragment from wild sequences paving the way for the novel diagnostic platform.
Altogether, the technique might be an old concept, but exploiting nanotechnology has
made it sensitive toward single-base mismatched DNA detection. This novel approach is
gaining attention in diagnostic purposes and can be explored further by the attachment of
functional moieties to improve sensitivity.
4.2.2. Electrochemiluminescence Detection
The classic electrochemistry approach used methods labeled with natural enzymes
or electro-molecules to yield the amplification signal. Nevertheless, this conventional
approach has problems of heavy background noise and nonspecificity [103]. Another main
challenge with the method above is the identification of different types of single-base mis-
matches. Hence, the technique was modified to enhance sensitivity and diagnostic ability.
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A modified similar technique that enables the efficient detection of SNPs is electrochemi-
luminescence (ECL). The most commonly used luminophore is Ru(bpy)32+ because of its
high ECL efficiency [104]. However, to further improve the sensitivity of the ECL technique,
ECL emission of Ru(bpy)32+ needs to be enhanced [105]. Recently, NPs have gained interest
in increasing the excitation rate and the emission factor of Ru(bpy)32+ to help in better
detection. The fluorescent nanomaterials are of special consideration in this regard due to
their photostability and fast emission rate. Polymer dots (Pdots) have been widely studied
in biosensing. They are advantageous over quantum dots (QDs) as they are nontoxic. A
recent study combined the luminescent Pdots encapsulated with Ru(bpy)32+ to develop the
double enhanced ECL mechanism for detecting SNPs. Poly(9,9-dioctylfluorenyl-2,7-diyl)
(PFO) was used as a carrier during the process of nanoprecipitation, poly(styrene-co-maleic
anhydride) (PSMA) as the functional reagent, and Ru(bpy)32+ as the ECL active molecule,
as shown in Figure 2. Excited Pdots transferred resonance energy to Ru(bpy)32+ that further
improved the emission intensity and led to high sensitivity in biodetection. The DNA-
functionalized Ru(bpy)32+-doped Pdots were developed to detect the KRAS mutant gene.
The Ru(bpy)32+-doped Pdots had an average size of 20 nm. These novel ultrasensitive ECL
nanoconjugates amplified the detection signal in the linear range from 1 fM to 1 nM [106].
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Figure 2. Schematic illustration of (A) the synthesis of a Ru(bpy)32+-doped Pdots nanoprobe using
PFO as a carrier and PSMA as a functional reagent, and (B) the detection of SNPs with nanoprobe
and ligase detection reaction. Reprinted with permission from ref. [106]. Copyright 2017 American
Chemical Society.
Another novel strategy for detecting SNPs uses carbon nanostructures that can be in
the form of carbon nanospheres, nanocapsules, nanotubes, or nanofibers. The graphene
quantum dots (GQDs) were developed in a study to detect DNA damage. These GQDs
were synthesized using any chemical reagent. Moreover, AuNPs were attached to the
single-stranded DNA probe (cp53 ssDNA) to improve the ECL mechanism. These AuNP-
ssDNAs, when attached to the GQDs, enhanced the ECL signal quenching of GQDs, and
when these AuNP-ssDNAs were hybridized with target p53 DNA, they formed AuNP-
dsDNAs leading to the recovery of the GQDs’ ECL. The developed nanosystem provided a
sensor platform for the efficient detection of SNPs and the quantification of aptamer-specific
biomolecules [107].
An interesting study emphasized the use of a label-free electrochemical biosensing
method. The biosensor comprised the Ag/platinum (Ag/Pt) bimetallic nanoclusters
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fixed on the triplex DNA template. Ag/Pt NPs were used due to their high stability
and synergistic effect compared with monometallic NPs. The X-shaped DNA probe was
fabricated with the triplex Ag/Pt nanoclusters and locked nucleic acid (LNA). The triplex
Ag/Pt nanoclusters were able to detect the SNPs related to β-thalassemia. The LNA
modified X-shaped triplex Ag/Pt nanoclusters were attached to the surface of the Au
electrode. This assembly dissociated in the presence of the target, causing the elevated
signal that detected the variant allele frequency in β-thalassemia [108].
Lately, a single platform for genotyping the SNPs was reported in which modified
NPs were utilized for electrochemical signals [109]. The linkers, cysteine and cysteamine
hydrochloride, were used to modify AgNPs and AuNPs. The bimetallic NPs were used
because of their high conductivity and enhanced electron transfer properties. The comple-
mentary monobases were anchored to the MNPs, and the mismatch targets were hybridized
by the monobase-linked MNPs in the presence of DNA polymerase I. This hybridization
was followed by the analytical signals for SNP genotyping, detected as electrooxidation
signals of AgNPs and AuNPs. The polymerase enzyme stimulated the coupling of the
mutant site of DNA (hemophilia gene sequence) to the monobase-linked MNPs. This
method allowed the detection of complementary targets with a linear range of 20–1000 pM
and 50–1500 pM of mutant DNA.
Similarly, chemiluminescence-based sensors have been explored encapsulated with
luminol, which works as a chemiluminescence illuminant. Silicon material has been used
in the past for antigen detection as a target-triggered signal chemiluminescence sensor. In
the presence of a specific antigen, e.g., prostate specific antigen, the antigen and its aptamer
are combined together. Once this happens, the aptamer mounted on the silica detaches,
and luminol is released to produce chemiluminescence in the wide linear range [110].
In another approach, a label-free biosensor was developed for detecting the I27L
gene variant that is responsible for diabetes. Luminol was used as a chemiluminescence
illuminant for the output signal. AuNPs were decorated with the substrate indium tin oxide.
The ITO electrode biosensor demonstrated high sensitivity toward mismatched DNA. The
electrode was functionalized with the polymer along with AuNPs using oligonucleotides as
a capture probe. As soon as the target DNA was hybridized, there was a significant increase
in the anionic charge of the electrode that further caused quenching of ECL intensity [111].
A novel ECL-based concept was used for the detection of SNP. A luminol-H2O2-
horseradish peroxide (HRP) system mimicking DNAzyme-fluorescein chemiluminescence
resonance energy transfer (CRET) magnetic NPs was developed. The quantitative analysis
of SNPs was possible by positive mutation detection. Furthermore, the imaging strategy
amplified the signal upon SNP detection along with chemiluminescence because of luminol
(https://doi.org/10.1016/j.bios.2014.10.025) (accessed on 20 May 2021).
This novel luminol-based biosensor has also been investigated for other biological
functions such as cancer cell detection. Luminol in Ag-PAMAM biocomposite was one
such approach based on ECL [112].
Molecular imaging technology has also been of interest among the chemiluminescence-
based approaches. Hydrogel polymers with molecular beacon (mb) probes were utilized to
form the microgels. By tuning the spatial distribution of molecular probes immobilized
on the microgel, it was possible to detect miRNA (miR-21) targets in human serum. The
system was highly sensitive as it was able to quantify even the lowest mutant target in a
sample of 20 µL. This approach can be further developed for biosensing with other probes,
such as aptamers [113].
Based on the aggregation-induced emission (AIE), a molecule TPBT, was used to
identify the dsDNA. A dual-color fluorescent signal in the red (~640 nm) and green zone
(~537 nm) was emitted. When the molecule binds with dsDNA and ssDNA, there was
an emission of red color. On the contrary, green light was emitted only in response to the
binding of TPBT with dsDNA exclusively. Hence, this made it possible to detect SNPs in
the damaged or mutated DNA with ultrahigh sensitivity. The method was a completely
label-free, robust, AIGen-based dsDNA assay [114].
Nanomaterials 2021, 11, 1384 9 of 20
The molecular fluorescence method has been in constant exploration for miRNA
detection via using a DNA probe (MB1). A hybridization chain reaction (HCR) was used
to develop DNA-based Ag nanoclusters. MB1 contains a poly-cytosine nucleotide loop.
An HCR monomer (MB2) with a poly-guanine nucleotide sticky end was developed. Both
the monomers co-existed in the solution until the SNP was detected, leading to decreased
fluorescence signal. This label-free method allowed the detection of polymorphism in
let-7a (miRNA) [115].
This ECL technology is up-and-coming in discovering SNPs and can be further char-
acterized in terms of safety, application protocol, and detection duration. With more
improvement, the technique can offer unlimited applications in the field of diagnosis in hu-
man health. A few other diagnostic platforms designed on the concept of nanodimensions
are mentioned in Table 1.
Table 1. Nanotechnology-based methods for SNP detection.
Technique Gene/Sequence Detected Disease Sensitivity Outcomes Ref.
Nanobased ligation
assay IVSII-1 (G > A) β-thalassemia
Frequency of 72% for





allele frequency of IVSII-1






Mismatch sequence Alzheimer’s disease
A 26% increase in the
electrochemical signal for










DNA(16189T→ C) Pancreatic carcinoma




(16189T→ C) was found
corresponding to












A single 12-mer sequence
from the H. pylori (HP1-SH)
and 100-mer sequence from




Detection of F508del, a
three-nucleotide (CTT)
deletion at the
508 position, in large
genomic DNA isolated
from blood cells and
H. pylori SNP detection
among other pathogens
from the concentration as









sequence and single gene

















BRCA1 gene Breast cancer
Detection of single-base
variation (A/G) at site
N47 on the BRCA1 gene
that leads to an SNP at
codon 504
Specific and selective
detection of SNPs by
using short DNA probes
[121]
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Nanomaterials have been extensively explored in the detection and diagnosis of
pathologies in humans [124–126]. One such approach based on nanomaterials uses single or
multilayered nanosheets made of transition metal dichalcogenide (TMD). TMD nanosheets
have various features, including electronic, chemical, and optical properties [127]. A recent
study has introduced Ta2NiS5 nanosheets as an amplification platform for SNP detec-
tion [128]. Dye-labeled DNA has been used as a probe to detect the mutant-type target. The
ternary chalcogenide nanosheet presents selectivity for the specific oligonucleotides of var-
ious lengths by quenching the fluorescence of dye-labeled DNA probes. This methodology
is highly sensitive to a single-base mismatch among the wild-type DNAs. Ta2NiS5 was used
as the target amplification biosensing tool. A wild-type (WT) target was used to distinguish
the SNP whereas, a dye-labeled DNA was used as a probe (P) for the identification of
mutant type targets (MTs), as shown in Figure 3.




Figure 3. A scheme of the fluorescent sensor composed of a Ta2NiS5 nanosheet to detect SNPs. 
Reprinted from ref. [128], Copyright © 2019 under the terms of the Creative Commons Attribution 
License (CC BY) (accessed on 24 April 2021). 
In another similar concept, a two-dimensional nanomaterial made of black-phospho-
rous nanosheets (BPs) was developed for biosensing. The surface-to-volume ratio of BPs 
can be enhanced by conjugation with functionalization molecules to improve the detec-
tion ability. Hence, nitrophenyl was used to enhance the selectivity power of BPs against 
ctDNA. The fluorescent-labeled ssDNA probe could be attached to the surface of nitro-
phenyl-functionalized BPs in the absence of the target ctDNA. The nitrophenyl BPs had 
higher quenching power toward ssDNA compared with double-stranded DNA. A highly 
efficient method increased the fluorescence up to 5.4 fold when the dye-labeled ssDNA 
probe formed the dsDNA in the presence of the target ctDNA. This particular platform 
can be used as a tool for diagnosing SNPs in the blood serum of cancer patients [129]. 
In the latest diagnostic studies regarding SNPs, graphene oxide (GO) has gained pop-
ularity. GO has been utilized in the amplification of the SNP detection signals. Normally, 
short dye-labeled DNA probes are used in GO applications as the short probes have low 
fluorescence ratios between complementary DNA and the sequence of SNP. The fluores-
cence of an unhybridized probe in the presence of a single-base mismatch can be 
quenched by GO. On the contrary, the fluorescence was observed in the presence of hy-
bridization of dsDNA with complementary target DNA. However, ideally, this is an im-
practical approach as the target sequences are usually longer, and GO has low fluores-
cence quenching ability for long-stranded ssDNA compared with short ssDNA. To un-
derstand the methodology of GO-based fluorescent nanosheets, a moderate sequence of 
DNA was used as a probe, whereas the complementary target was a portion of the Esche-
richia coli gene sequence. The fluorometric-DNA-modified GO nanosheets exhibited ex-
cellent biosensing properties against the single-base mismatch. The targets had higher flu-
orescence when the dye was tagged at the 5′ end of the probe, and the mismatched base 
was near the 5′ end than when it was near the 3′ end. Altogether, the results were highly 
sensitive to the single-base mismatch, and the results were similar for both the short and 
long target DNAs [130]. 
In another study, metallic and semiconductor MoS2 nanosheets were fabricated for 
the fluorescence quenching against the fluorophore-labeled ssDNAs. MoS2 nanosheets 
were exploited to detect SNPs based on the principle of fluorescence quenching and chem-
ical exfoliation. The ultrathin nanosheets made of metallic MoS2 had higher quenching 
efficiency compared with the semiconductor MoS2 nanosheets. The multiplex detection 
biosensor was used to discriminate the ssDNA and dsDNA labeled with various fluoro-
phores efficiently in one solution with high precision [131]. 
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In another similar concept, a two-dimensional nanomaterial made of black-phospho-
rous nanosheets (BPs) was developed for biosensing. The surface-to-volume ratio of
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BPs can be enhanced by conjugation with functionalization molecules to improve the
detection ability. Hence, nitrophenyl was used to enhance the selectivity power of BPs
against ctDNA. The fluorescent-labeled ssDNA probe could be attached to the surface of
nitrophenyl-functionalized BPs in the absence of the target ctDNA. The nitrophenyl BPs had
higher quenching power toward ssDNA compared with double-stranded DNA. A highly
efficient method increased the fluorescence up to 5.4 fold when the dye-labeled ssDNA
probe formed the dsDNA in the presence of the target ctDNA. This particular platform can
be used as a tool for diagnosing SNPs in the blood serum of cancer patients [129].
In the latest diagnostic studies regarding SNPs, graphene oxide (GO) has gained
popularity. GO has been utilized in the amplification of the SNP detection signals. Normally,
short dye-labeled DNA probes are used in GO applications as the short probes have
low fluorescence ratios between complementary DNA and the sequence of SNP. The
fluorescence of an unhybridized probe in the presence of a single-base mismatch can
be quenched by GO. On the contrary, the fluorescence was observed in the presence
of hybridization of dsDNA with complementary target DNA. However, ideally, this is
an impractical approach as the target sequences are usually longer, and GO has low
fluorescence quenching ability for long-stranded ssDNA compared with short ssDNA. To
understand the methodology of GO-based fluorescent nanosheets, a moderate sequence
of DNA was used as a probe, whereas the complementary target was a portion of the
Escherichia coli gene sequence. The fluorometric-DNA-modified GO nanosheets exhibited
excellent biosensing properties against the single-base mismatch. The targets had higher
fluorescence when the dye was tagged at the 5′ end of the probe, and the mismatched base
was near the 5′ end than when it was near the 3′ end. Altogether, the results were highly
sensitive to the single-base mismatch, and the results were similar for both the short and
long target DNAs [130].
In another study, metallic and semiconductor MoS2 nanosheets were fabricated for the
fluorescence quenching against the fluorophore-labeled ssDNAs. MoS2 nanosheets were
exploited to detect SNPs based on the principle of fluorescence quenching and chemical ex-
foliation. The ultrathin nanosheets made of metallic MoS2 had higher quenching efficiency
compared with the semiconductor MoS2 nanosheets. The multiplex detection biosen-
sor was used to discriminate the ssDNA and dsDNA labeled with various fluorophores
efficiently in one solution with high precision [131].
A similar study explored the potential of four TMD nanosheets of WS2, MoS2, WSe2,
and MoSe2 based on a metal-ion-induction approach. Their specificity was assessed against
the ssDNA and dsDNA, and the growth of the nanosheets improved along with thickness
with an increase in the amount of metal ion concentration. However, the conjugation
between ssDNA and TMD nanosheets was disturbed when the ssDNA hybridized with
complementary DNA. The nanosheets were found to be dispersed with a higher metal
ion concentration. This feature then enhanced the detection of SNPs with accuracy by
the label-free calorimetric approach [132]. Therefore, based on all these studies, it can be
stated that nanomaterials designed as nanosheets hold potential in detecting SNPs and
need further exploration for toxicity evaluation and clinical translation.
4.4. Miscellaneous Nanobased Detection of SNPs
Various other nanobased systems have been developed, characterized, and explo-
red [133–135]. Because of the colloidal stability and electro-optical properties, AuNPs
have gained attention in the past for diagnostic purposes. The conductive electrons in
the metallic core undergo oscillations in the presence of an external electromagnetic field
that generates surface plasmon resonance. This makes the AuNPs useful in biosensing
with a high absorption index and almost no photobleaching. Figure 4 summarizes the idea
of the detection of DNA damages in different approaches. Figure 4a shows the concept
of aggregation upon subsequent hybridization of ssDNA adhered on AuNPs with target
oligonucleotide. The method is accurate and reports no false positives. Figure 4b shows the
nonselective aggregation of one type of DNA-coated AuNP based on the non-crosslinking
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method to detect SNP. The presence of a single point mutation at the 5′ end provides col-
loidal stability to the NPs due to the steric effect. However, the gradual aggregation occurs
in the presence of a perfect-match sequence by decreasing steric repulsion. Figure 4c shows
the use of citrate-stabilized AuNPs instead of DNA-coated NPs. The citrate-stabilized
AuNPs have a high affinity for the ssDNA compared with dsDNA. This might be because
ssDNA has high electrostatic linkage with AuNPs due to elevating the number of functional
groups [136].




Figure 4. AuNP-based colorimetric assays. (a) Crosslinking hybridization assay leading to color 
change upon the detection of specific DNA hybridization. (b) Non-crosslinking method causing 
the aggregation of the NPs in the absence of a complementary target. (c) Unmodified NP-based 
colorimetric assay in which the ssDNA stabilizes the AuNPs against aggregation, and NPs un-
dergo aggregation in the presence of dsDNA. Reprinted from ref. [136], under the Creative Com-
mons Attribution License (https://creativecommons.org/licenses/by/4.0)(accessed on 24 April 
2021). 
AuNPs stabilized with DNA have also been studied extensively for use in SNP de-
tection. The single-base mismatch can easily be detected among the wild-type DNA frag-
ments. AuNPs have expressed excellent results in liquid biopsies. DNA-coated AuNPs 
can discriminate the SNP in less than 10 min without the need for amplification. The NPs 
were incubated with the liquid sample, and the solution remained un-aggregated in the 
presence of the target sequence [137]. 
An ultrasensitive DNA biosensor was developed that used DNA-templated Ag dep-
osition from AgNPs along with electrochemical atom transfer radical polymerization sig-
nal amplification (eATRP). The target DNA was successfully captured when the thiol-
functionalized peptide nucleic acid (PNA) probe was used, modified as an Au electrode. 
The DNA template was bound with a PNA probe based on the phosphate group func-
tionalization of the thiol via an initiator (α-bromophenylacetic acid). The AgNPs depos-
ited on the electrode, and the concentration of AgNPs proportional to the DNA template 
were quantified using differential pulse voltammetry. This modification facilitated the de-
tection of SNPs with high sensitivity [138]. 
Figure 4. AuNP-based colorimetric assays. (a) Crosslinking hybridization assay leading to color
change upon the detection of specific DNA hybridization. (b) Non-crosslinking method causing
the aggregation of the NPs in the absence of a complementary target. (c) Unmodified NP-based
colorimetric assay in which the ssDNA stabilizes the AuNPs against aggr gation, and NPs undergo
aggregation in the presence of dsDNA. Reprinted from ref. [136], under the Creative Commons
Attribution License (https://creativecommons.org/licenses/by/4.0) (accessed on 24 April 2021).
AuNPs stabilized with DNA have also been studied extensively for use in SNP
detection. The single-base mismatch can easily be detected among the wild-type DNA
fragments. AuNPs have expressed excellent results in liquid biopsies. DNA-coated AuNPs
can discriminate the SNP in less than 10 min without the need for amplification. The NPs
were incubated with the liquid sample, and the solution remained un-aggregated in the
presence of the target sequence [137].
An ultrasensitive DNA biosensor was developed that used DNA-templated Ag de-
position from AgNPs along with electrochemical atom transfer radical polymerization
signal amplification (eATRP). The target DNA was successfully captured when the thiol-
functionalized peptide nucleic acid (PNA) probe was used, modified as an Au electrode.
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The DNA template was bound with a PNA probe based on the phosphate group function-
alization of the thiol via an initiator (α-bromophenylacetic acid). The AgNPs deposited
on the electrode, and the concentration of AgNPs proportional to the DNA template were
quantified using differential pulse voltammetry. This modification facilitated the detection
of SNPs with high sensitivity [138].
Another novel modality was using an ultrasensitive electrochemical method based on
an urchin-like carbon nanotube–AuNP conjugate (CNT-AuNP) nanoclusters. Dopamine
was used to modify the Au electrode for DNA probe immobilization. The DNA-functiona-
lized AuNPs were introduced in the sensing system via DNA hybridization after detecting
the target. The electrochemical signal was generated when the CNT with DNA was linked
to the AuNPs (Figure 5). The 3D nanostructure presented a high sensitivity for the detection
of SNPs under optimal conditions [139].
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Mesoporous silica NPs have also been explored for the detection of SNPs in the
case of β-thalassemia. A detection probe based on mesoporous silica NPs loaded with
fluorescein molecules was developed to detect IVS110 point mutation (A > G reversion).
Their hybridization with PCR-amplified ssDNA targets yielded different fluorescent signals
for mutated targets [140]. The surface plasmon resonance method was another widely
explored platform for detecting SNPs. One such use was the identification of the APOE
gene that is linked with Alzheimer’s disease. The absence of a single-base mismatch to the
pre-immobilized biotinylated probes began the cleavage by the HhaI restriction enzyme.
However, the cleavage was prevented in the presence of the single-base mismatch. The
procedure was label-fre a d straightf rward and provided s nsitive detection of t SNP
linked to Alzheim r’s disease [141].
More unique m thods we explored for the detection of SNPs. The latest study
focused on the biosensing m thod using the MutS protein of a bact ia-merged fiber optic
particle plasmon resonance (FOPPR) sensi g system. Th MutS protein adhered to the
AuNPs that were de osited on the surface of optical fiber. The mismatched D pair
was identified by the MutS protein, causing increased absorption of green light. When
the MutS protein adhered on the AuNP’s surface interacted with a dsDNA mismatch,
the refractive index increased at the AuNP surface resulting in a significant increase in
the sensing sensitivity. MutS protein was explored because it initiates DNA repair in
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Escherichia coli after binding with base-pair mismatched DNA and, hence, can be used to
detect SNPs. The strategy successfully rapidly identified the mismatched dsDNA with a
label-free approach. The FOPPR method facilitated the sensing of dsDNA with its sensor
chip containing a sensor fiber [142].
5. Challenges in Detecting SNPs via Nanotechnology-Based Methods
Nevertheless, there are considerable obstacles to overcome, and extra effort will be
needed to improve the flexibility and detection efficiency of SNP mutation tests. Mul-
tiplexed identification is a significant property for high diagnostic accuracy, and some
nanotechnological strategies hold great promise in this regard. However, despite consider-
able progress, many limitations must be overcome before clinical diagnostic assays can be
established. Although some experiments have recorded aM and even zM responsiveness,
most of these observations are still in the proof-of-concept phase and were performed in
clean buffers. Thus, they have not been evaluated in clinically relevant media such as blood,
serum, saliva, or urine yet. Moreover, due to the extreme heavy interference from back-
ground DNAs, most assessments have registered a very low SNP specificity ratio (10 fold),
rendering them potentially inappropriate for detecting low-abundant disease-related SNPs
in the background of wild-type gene/genomic DNA.
Furthermore, the lack of multiplexing capacity may be a major challenge to realizing
the clinical potential. Another significant consideration for nano-enabled SNP biosensors
is the sustainability of biofunctionalized nanomaterials. In this aspect, a thorough under-
standing of biomolecule–nanomaterial interactions is critical to address issues with high
background signals caused by nonspecific adsorptions in serum and/or other complex
clinical samples. These also call for enhancing the assays’ automation and miniaturization
capabilities, as most existing assays still require using costly and complex equipment and
protocols, restricting their capacity for rapid detection.
The current nanotechnology-based diagnostic methods, however, face certain chal-
lenges. As nanoparticles can vary from simplest to complex in terms of synthetic methods,
their commercialization becomes a problem. Moreover, the reproducibility of each method
on a large scale remains questionable. Nanotechnology holds promise in lab settings, but
it is difficult to scale up clinically due to certain other factors such as characterization
and quality control. The characterization techniques are critical to the evaluation of the
diagnostic nanocarriers. Furthermore, the methods should also be validated for the early
detection of toxicity of the nanocarriers. Though physical and chemical stability have
been studied throughout the phases of various stages of fabrication of NPs, the in vivo
biodistribution, absorption, and elimination are still ambiguous. Adequate knowledge of
the interaction of the diagnostic nanocarriers with biological membranes is also a question
that needs extensive research prior to clinical translation. Altogether, there are currently
no regulatory guidelines available for the commercialization of nanotechnology-based
diagnostic approaches. Furthermore, the clinical study design needs a thorough evaluation
to recruit the nanoproducts to study the toxicity/safety to the population.
In addition, existing nano-biosensing technology-based SNP detection methods tend
to work well only under some DNA sequence conditions with short DNA and can only
recognize a specific sequence and, therefore, are not suitable for universal SNP detection.
Several ingenious ways to design nanomaterials for signal amplification strategies have
also been developed, including the use of multiple tagging and enrichment of nanoparticle
probes with signal moieties to enable ultrasensitivity. Some of these strategies also hold
great promises for multiplexed detection, an essential property for high diagnostic accuracy.
6. Conclusions and Outlook
For many decades, PCR methods have been used for detecting SNPs or point muta-
tions. Over the past few years, however, remarkable advances have been made in designing
biodiagnostic tools for detecting low-abundance SNPs/mutations and genetic mutations
with higher sensitivity and accuracy, mainly in terms of incorporating more advanced
Nanomaterials 2021, 11, 1384 15 of 20
DNA amplification methods with biofunctionalized nanomaterials. The significance of
these advances is that these new strategies, including NP-target-assisted PCR (or probe)
amplification, NP-enhanced signal amplification, target cycling coupled with probe am-
plification, etc., allow detection of low-concentration SNPs down to the aM–zM range
and suggest efficient approaches to improve screening ability from limited DNA material
via multiplex PCR methods. Based on the extensive research, it can be concluded that
NPs facilitate the implementation of assays to detect genetic defects from the biological
samples. Coupling the NPs with DNA-based amplification tools can further improve the
sensitivity and precision of the detection. This can be helpful in real-time assays, and with
further studies, it can be incorporated into the point-of-care diagnosis. Miniaturization and
automation are possible with electrochemical signal transduction, but these approaches
are vulnerable to false positives. Recent developments in microfluidics may be able to
help SNP assays overcome sample throughput and automation issues. If we can overcome
these obstacles, automation of these ultrasensitive assays may lead to integrating sample
processing, quantitative determination, and signal measurement in a single system in a
real-world clinical environment. This would make quick and precise disease diagnosis and
prognosis much easier. As a result, these are still important issues that must be resolved,
and further work will be needed to enhance the analytical sensing efficiency and portability
of SNP experiments.
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